Format: Download Video of Slides with Synchronized Audio

Presenter: Alan Bauman, MD

Androgenetic Alopecia or hereditary hair loss, considered by many as an outward and undesirable sign of premature aging that can be ‘seen from across the room,’ currently affects an estimated 50 Million men and 30 Million women in the U.S. Approximately 40% of men in their 40’s are experiencing hair loss and 50% of men in their 50’s with over a billion dollars spent in the U.S. annually on medical treatments, hair transplants, non-medical ‘cures’ and cover-ups to address the condition. But what if the androgen replacement therapy you prescribed caused an unexpected and undesirable side-effect of acceleration of hereditary patterned hair loss? Hormone replacement therapy (HRT) that includes androgens may accelerate the progression of unwanted androgenetic alopecia, especially in those patients whose hair follicles are highly androgen sensitive.

Learning Objectives:
-> Enhances the risk/benefit discussion with the HRT patient.
-> Identifies and addresses a possible side effect and potential barrier to HRT compliance.
-> Adds a beneficial service to the Age Management Physician’s repertoire that may enhance patient retention.
-> Successful hair loss management adds a psychological boost to a HRT patient’s outlook.